Download PDF
1 / Pages

Other users also viewed these articles

Outcomes and risk factors for mortality in clostridioides difficile infection in patients with NAFLD and NASH Ankoor H. Patel; Gaurav N. Pathak; Alexander Chen; Patricia Greenberg; Natale Mazzaferro; Anish Patel; Naveen Mallangada; Carlos D. Minacapelli; Kaitlyn Catalano; Hansel Suthar; Vinod K. Rustgi;
10.1016/j.aohep.2024.101510
Liver steatosis and fibrosis markers¿ association with cardiovascular and renal damage in Japanese adults: the TMM BirThree cohort study Toshiya Machida; Taku Obara; Mami Ishikuro; Keiko Murakami; Fumihiko Ueno; Aoi Noda; Tomomi Onuma; Fumiko Matsuzaki; Jun Inoue; Shinichi Kuriyama; Nariyasu Mano;
Ann Hepatol. 2023;28:
Oral 24-week probiotics supplementation did not decrease cardiovascular risk markers in patients with biopsy proven NASH: A double-blind placebo-controlled randomized study Samantha Thifani Alrutz Barcelos; Amanda Souza Silva-Sperb; Helena Abadie Moraes; Larisse Longo; Bruna Concheski de Moura; Matheus Truccolo Michalczuk; Carolina Uribe-Cruz; Carlos Thadeu Schmidt Cerski; Themis Reverbel da Silveira; Valesca Dall'Alba; Mário Reis Álvares-da-Silva;
Ann Hepatol. 2023;28: